Dr. Brian Loggie

Quick Summary

Dr. Brian Loggie is an extraordinarily accomplished surgical oncologist, with nearly four decades experience. He is known for his ability and willingness to treat individuals with Stage 4 and terminal cancers, extending the life of individuals who seemingly had no options.

“When I started, we had very little treatment. I started an experimental protocol to operate on these patients, remove the tumors—they always came back after surgery if you didn’t do anything else—so we added heated intraperitoneal chemotherapy as a profusion at the end surgery and we were kind of astonished by the results. Based on how patients did before that, we weren’t expecting to see very many 1 year survivors, so when we started seeing 1, and 2, and 3, and 5 year survivors,” said Dr. Loggie.

Dr. Loggie pioneered heated chemotherapy, a technique which can manage or eliminate some complex forms of abdominal cancer, including peritoneal mesothelioma. Heated chemotherapy was a significant innovation in mesothelioma treatment and has the potential to eliminate the cancer.

Dr. Loggie’s Location

Dr. Loggie currently has admitting privileges at Boys Town National Research Hospital and CHI Health’s Creighton University Medical Center.

CHI Health Clinic

7710 Mercy Road, Suite 2000

Omaha, NE 68131

(402) 280-4100

Dr. Loggie’s Career Highlights

Dr. Loggie has led an inspiring career, his highlights including:

  • Pioneered heated chemotherapy treatments for peritoneal cancer
  • Specializes in the treatment and management of rare complex cancers like mesothelioma
  • Director of the Cancer Center at Creighton University Medical Center
  • Former director of Mesothelioma Applied Research Foundation, developing new and improved treatments for mesothelioma treatment

Dr. Loggie’s Background

Dr. Loggie obtained his MD at McGill University in Montreal, Canada, before completing his internship and residency at the Montreal General Hospital. While a resident, Dr. Loggie also earned a graduate degree from the Department of Experimental Surgery at McGill University. He then completed a Clinical and Research Fellowship in Surgical Oncology at the University of Illinois.

He continued to refine his knowledge and expertise throughout the years, completing several courses and programs, including:

  • Specialist Certificate in General Surgery – Royal College of Physicians and Surgeons of Canada
  • Certificate of Training in Surgical Oncology – University of Illinois School of Medicine
  • General Surgery – American Board of Surgery

Dr. Loggie Background Update

Dr. Loggie has held teaching positions at numerous institutes, including the University of Illinois at Chicago, Bowman Gray School of Medicine, and University of Texas Southwestern Medical Center.


While working at Wake Forest University Baptist Medical Center in Winston-Salem, NC, Dr. Loggie developed hyperthermic intraperitoneal chemotherapy (HIPEC), also called heated chemotherapy, which can successfully treat many late-stage abdominal cancers.

He is currently a surgical professor at the Creighton University School of Medicine in Omaha, NE.

Medical Specializations

Dr. Loggie specializes in complex surgical oncology, focusing on the treatment of rare and aggressive cancers including tumors and mesothelioma. He is known for developing effective management and treatment plans for patients with late-stage cancer, who have minimal remaining options. He also specializes in heated chemotherapy, a highly effective mesothelioma treatment procedure that he developed.

Dr. Loggie’s Career Accomplishments

Dr. Loggie has had a long and established career, with numerous accomplishments along the way.

Dr. Loggie is best known for his development of or heated chemotherapy, a procedure that has been successful in treating peritoneal mesothelioma and late-stage abdominal cancers. Most patients meet Dr. Loggie after receiving a grim prognosis from other medical facilities, and his heated chemotherapy has been a literal lifesaver for many of them.

Dr. Loggie also provides treatment for individuals with terminal cancers, sometimes adding five or more years to their life expectancy. Patients’ overall health and wellness can drastically improve under Dr. Loggie’s, even if the cancer isn’t completely eliminated. In these cases, his goal is to improve a patient’s quality and length of life.

Dr. Loggie is a champion for patients with rare forms of cancer, drawing research and funding to areas of oncology that are often overlooked by the general population.

Awards & Honours

Dr. Loggie is a highly accomplished specialist and a true medical leader. It’s no wonder he has received so many awards and honors, including:

  • The Best Doctors in America (peer selected)
  • Castle Connoly’s America’s Top Doctors
  • The Dr. Harold J. Bonnstetter Endowed Chair in Preventive Medicine
  • 2010 Magis Award from Creighton University
  • CMS Meaningful Use Stage 1 Certification

Dr. Loggie’s Current Work

Dr. Loggie is currently Chief of the Surgical Oncology division and Director of Creighton’s Cancer Center, where he focuses on the management and treatment of mesothelioma and other rare cancers. He is also part of the surgical faculty at the Creighton University School of Medicine, teaching the next generation of oncologists.

Dr. Loggie is a member of more than a dozen professional societies and organizations, including:

  • Director – Mesothelioma Applied Research Foundation (MARF)
  • Fellow – Society of Surgical Oncology
  • Fellow – American College of Surgeons
  • Fellow – Royal College of Surgeons of Canada
  • Member – Association for Academic Surgery
  • Member – American Society of Clinical Oncology (ASCO)
  • Member – International Society for Regional Cancer Therapy

Notable Works by Dr. Loggie

Dr. Loggie has made massive contributions to the peritoneal mesothelioma treatment landscape. Today, Dr. Loggie’s is recognized as the developer of what was once considered a novel treatment approach. In 2001, Dr. Loggie published his results from a prospective trial that studied this new therapy to treat peritoneal mesothelioma.

The purpose of the trial was to test the effectiveness of using cytoreduction (tumor-debulking) surgery in combination with intraoperative intraperitoneal heated chemotherapy, a therapy now known as HIPEC. Dr. Loggie conducted this treatment approach on multiple patients. Following the cytoreductive surgery, which removed as much of the tumors as possible, Dr. Loggie administered heated chemotherapy drugs directly into the patients’ abdominal cavities for two hours.

The vast majority of patients involved in this trial significantly improved their survival time. At the time Dr. Loggie had published his results, one patient remained disease-free for five years. Though it as novel at the time, today this approach has become a standardized and highly effective treatment for patients with peritoneal mesothelioma.

Dr. Loggie’s Healing Philosophy

CHI Health’s Creighton Medical Clinic believes in “value-based care,” a philosophy that puts people at the forefront of medical solutions. By helping people get healthy and stay that way, Creighton cuts down on costs without cutting quality.

According to CHI Health, “The Mission of Catholic Health Initiatives is to nurture the healing ministry of the Church, supported by education and research. Fidelity to the Gospel urges us to emphasize human dignity and social justice as we create healthier communities.”

This faith-based health ministry utilizes medical work and science to treat patients, balanced with the spiritual and mental wellness patients can receive from God. The core values of CHI are Reverence, Integrity, Compassion, and Excellence.

To work with Dr. Loggie, mesothelioma patients can contact CHI Health at 402-280-4100 to book an appointment and get started on an advanced mesothelioma treatment plan.

View Author and Sources
Author

Sources
  1. CHI Health Clinic. “Brian Loggie, M.D.” Retrieved from http://www.chihealth.com/body.cfm?id=139&action=detail&ref=3603 . Accessed November 5th, 2017.
  2. CHI Health News Center. “Hope For Those Who Don’t Have Any.” Retrieved from http://www.chihealth.com/body.cfm?id=5465&action=detail&parent=5304&ref=9. Accessed November 5th, 2017.
  3. FirstScan Omaha. “Brian W. Loggie, MD CM, FRCSC, FACS.” Retrieved from http://firstscanomaha.com/brian-loggie/. Accessed November 5th, 2017.
  4. PubMed: US National Library of Medicine. “Author: Loggie, BW.” Retrieved from https://www.ncbi.nlm.nih.gov/pubmed. Accessed November 5th, 2017.
  5. YouTube. “CHI Health Dr. Brian Loggie.” Retrieved from https://www.youtube.com/watch?v=xUXpPzIMLB8 . Accessed November 11th, 2017.
  6. National Institutes of Health, “Prospective trial for the treatment of malignant peritoneal mesothelioma.” Retrieved from: https://www.ncbi.nlm.nih.gov/pubmed/11603562. Accessed on November 12th, 2017.

Last modified: May 7, 2018